Requesting Joint Committee on Government and Finance study smoke shops
Senate Concurrent Resolution 26 requests that the Joint Committee on Government and Finance study smoke shops in West Virginia and the products they sell, with particular attention to tobacco and nicotine products, products sold to minors, and the legality and safety of items such as CBD, kratom, and cannabis-related products. The resolution cites a reported surge in smoke shops across the state and expresses concern that some products may be illegal, unsafe for human consumption, or otherwise inconsistent with federal Food and Drug Administration guidance.
The study is directed to examine the scope of smoke shop sales, the distribution chain for products sold in these stores, where illegal products are sourced, and how they are delivered into West Virginia. The committee is also asked to assess the health risks posed by these products and to return in 2026 with findings, conclusions, recommendations, and draft legislation if needed. The resolution itself does not change substantive law, but it sets up a legislative review that could lead to future regulation or enforcement measures.
SCR26 has no immediate effect on state statutes or regulatory requirements; instead, it authorizes and funds a legislative study through the Joint Committee on Government and Finance. Its practical impact is to place smoke shops, tobacco and nicotine sales, youth access, and the regulation of CBD, kratom, and cannabis-related products under formal legislative review, potentially paving the way for future bills, enforcement changes, or licensing and product-safety rules.
The resolution appears to reflect broad concern among its sponsors about youth access, public health, and the proliferation of potentially illegal or unsafe products in smoke shops. Because there are no recorded committee transcripts or votes provided, there is no evidence of formal opposition in the available record. The overall tone of the measure is precautionary and investigative rather than punitive, emphasizing study and recommendations before any direct regulatory action.
The main points of contention implied by the text are the legality and safety of products sold in smoke shops, especially products marketed to minors or products that may fall outside FDA or state agricultural standards. Another likely area of debate is the scope of state regulation over tobacco, nicotine, CBD, kratom, and cannabis-related items, including how aggressively West Virginia should police retail sales and supply chains. The resolution does not identify specific opponents, but the subject matter suggests tension between public-health advocates, regulators, and retailers or industry interests that may resist tighter oversight.